Concepedia

Publication | Closed Access

Benefit of interferon β-1a on MSFC progression in secondary progressive MS

DOI

403

Citations

33

References

2002

Year

Jeffrey A. Cohen, Gary Cutter, Jill S. Fischer, Andrew Goodman, Fedor Heidenreich, Mariska Kooijmans, AW Sandrock, Richard A. Rudick, Jack H. Simon, Nancy A. Simonian,
Neurology

Abstract

IFNbeta-1a demonstrated benefit on MSFC progression, relapses, quality of life, and MRI activity in SPMS.

References

YearCitations

Page 1